Announcements
- Enovis to Participate in Upcoming Investor Conferences
- Enovis Announces First Quarter 2024 Results
- Enovis to Host First Quarter 2024 Results Conference Call on May 2nd
- Enovis to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- Enovis Announces Fourth Quarter and Full Year 2023 Results
- Enovis™ to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual Meeting
- Enovis to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024
- Enovis Showcases New Foot & Ankle Offerings at the ACFAS Annual Meeting
- Enovis to Host Fourth Quarter and Full Year 2023 Conference Call on February 22nd
- Enovis Introduces the DonJoy ROAM™ OA Knee Brace
More ▼
Key statistics
On Wednesday, Enovis Corp (C520:FRA) closed at 43.20, 4.85% above its 52-week low of 41.20, set on Oct 27, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 43.20 |
---|---|
High | 43.20 |
Low | 43.20 |
Bid | 44.00 |
Offer | 44.40 |
Previous close | 44.60 |
Average volume | 0.00 |
---|---|
Shares outstanding | 54.85m |
Free float | 51.68m |
P/E (TTM) | -- |
Market cap | 2.76bn USD |
EPS (TTM) | -1.89 USD |
Data delayed at least 15 minutes, as of Jun 05 2024 08:09 BST.
More ▼